Brewin Dolphin Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$308K Hold
950
0.03% 106
2022
Q1
$272K Hold
950
0.03% 117
2021
Q4
$262K Hold
950
0.03% 121
2021
Q3
$219K Hold
950
0.03% 129
2021
Q2
$218K Hold
950
0.03% 126
2021
Q1
$177K Buy
950
+174
+22% +$34K 0.03% 119
2020
Q4
$131K Hold
776
0.02% 121
2020
Q3
$115K Buy
776
+36
+5% +$5.57K 0.02% 123
2020
Q2
$121K Buy
740
+140
+23% +$21.5K 0.03% 122
2020
Q1
$83.2K Hold
600
0.04% 93
2019
Q4
$78.9K Hold
600
0.04% 104
2019
Q3
$67.1K Hold
600
0.03% 102
2019
Q2
$66.5K Hold
600
0.03% 107
2019
Q1
$77.9K Hold
600
0.04% 96
2018
Q4
$69.4K Hold
600
0.04% 95
2018
Q3
$64.4K Hold
600
0.03% 104
2018
Q2
$51.2K Hold
600
0.03% 105
2018
Q1
$46.4K Hold
600
0.03% 108
2017
Q4
$50.7K Buy
+600
New +$51.1K 0.03% 103

Other funds holding LLY

Brewin Dolphin Wealth Management's LLY Position: Q2 2022 in Review

Brewin Dolphin Wealth Management held its Eli Lilly (LLY) position steady in Q2 2022 at 950 shares worth $308K. The position accounts for 0.03% of the portfolio, ranked #106.

Brewin Dolphin Wealth Management first reported a position in LLY in Q4 2017 and has held it in 19 quarters since. 2,445 funds tracked by Wall St. Rank hold LLY as of Q2 2022.

  • Brewin Dolphin Wealth Management held 950 shares of Eli Lilly worth $308K as of Q2 2022.
  • Brewin Dolphin Wealth Management left its Eli Lilly share count unchanged in Q2 2022.
  • Eli Lilly made up 0.03% of Brewin Dolphin Wealth Management's portfolio in Q2 2022, its #106 holding.
  • Brewin Dolphin Wealth Management first reported a position in Eli Lilly in Q4 2017 and has held it in 19 quarters since.
  • 2,445 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2022.

Based on Brewin Dolphin Wealth Management's 13F filing for Q2 2022, filed 14 Nov 2022.